Use of filter paper for the collection and analysis of human whole blood specimens
Use of filter paper for the collection and analysis of human whole blood specimens
复制标题
DOI：
10.1093/jn/131.5.1631s
复制
发表时间：
2001-05-01
影响因子：
4.2
通讯作者：
Hannon, WH
中科院分区：
文献类型：
--
作者：
Mei, JV;Alexander, JR;Hannon, WH
疾病控制和预防中心及其合作伙伴一直在运作新生儿筛查质量保证计划> 20年。该计划通过为筛查计划的外部评估提供质量控制干血斑材料和能力测试材料，帮助参与实验室评估和提高其新生儿筛查测试工作的质量。新生儿筛查质量保证计划提供了对经食品和药物管理局批准用于临床试验血液采集的滤纸的独立评估。这些活动建立了一种机制，用于验证滤纸采血装置，并使干血斑分析的材料和方法标准化。
The Centers for Disease Control and Prevention and its partners have been operating the Newborn Screening Quality Assurance Program for > 20 y. The program helps participating laboratories to evaluate and improve the quality of their newborn-screening testing efforts by providing quality control dried blood spot materials and proficiency-testing materials for the external evaluation of screening programs. The Newborn Screening Quality Assurance Program provides an independent evaluation of filter papers approved by the Food and Drug Administration for the collection of blood for clinical tests. These activities have created a mechanism for the validation of the filter paper blood collection device and the standardization of materials and methods for the analysis of dried blood spots.